Sandoz
Clinical trials sponsored by Sandoz, explained in plain language.
-
Could a cheaper keytruda copy work just as well for melanoma?
Disease control OngoingThis study tests whether GME751, a proposed copy of the cancer drug Keytruda, works similarly in people with stage II or III melanoma whose tumors were removed by surgery. About 322 adults will receive either GME751 or Keytruda to compare how the drug moves through the body, its …
Phase: PHASE1 • Sponsor: Sandoz • Aim: Disease control
Last updated May 26, 2026 05:19 UTC
-
Generic asthma inhaler study pulled before starting
Disease control TerminatedThis study aimed to see if a generic version of the asthma inhaler fluticasone furoate/vilanterol works as well as the brand-name Breo Ellipta in adults with asthma. Participants would have taken the inhaler daily for 4 weeks and used a rescue inhaler as needed. However, the stud…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New study tracks IBD patients on biosimilar hyrimoz®
Knowledge-focused OngoingThis study observes 562 adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are starting or switching to Hyrimoz®, a biosimilar to adalimumab. Researchers will track how many patients continue the treatment after 6 months and why some stop, such as …
Sponsor: Sandoz • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC